{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:17:42Z","timestamp":1780370262274,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.acvd.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T06:52:12Z","timestamp":1434178332000},"page":"398-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions"],"prefix":"10.1016","volume":"108","author":[{"given":"Guillaume","family":"Schurtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lemesle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2015.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/01.CIR.102.11.1216","article-title":"It's time for a change to a troponin standard","volume":"102","author":"Jaffe","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.04.002_bib0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.04.002_bib0015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2015.04.002_bib0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0735-1097(01)01388-2","article-title":"The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis","volume":"38","author":"Heidenreich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrcardio.2013.129","article-title":"Cardiac troponin level elevations not related to acute coronary syndromes","volume":"10","author":"Giannitsis","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0030","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1093\/eurheartj\/sul026","article-title":"Clinical application of the natriuretic peptides in heart failure","volume":"8","author":"Chen","year":"2006","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.acvd.2015.04.002_bib0035","doi-asserted-by":"crossref","first-page":"H17","DOI":"10.1152\/ajpheart.00684.2005","article-title":"Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications","volume":"290","author":"Clerico","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2015.04.002_bib0045","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/CIRCULATIONAHA.106.666255","article-title":"N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study","volume":"115","author":"Moe","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.04.002_bib0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa031681","article-title":"Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea","volume":"350","author":"Mueller","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2015.04.002_bib0055","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2015.04.002_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"de Bold","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.acvd.2015.04.002_bib0065","first-page":"H143","article-title":"Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?","volume":"246","author":"Bussien","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0070","first-page":"341","article-title":"Molecular biology of vasopressin receptors","volume":"14","author":"Carmichael","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0075","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/hc4501.099313","article-title":"Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure","volume":"104","author":"Udelson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.04.002_bib0080","first-page":"341","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level","volume":"29","author":"Katan","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.acvd.2015.04.002_bib0085","doi-asserted-by":"crossref","first-page":"w13101","DOI":"10.4414\/smw.2010.13101","article-title":"The stress hormone copeptin: a new prognostic biomarker in acute illness","volume":"140","author":"Katan","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.acvd.2015.04.002_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2005.01.043","article-title":"Possible vascular role of increased plasma arginine vasopressin in congestive heart failure","volume":"106","author":"Nakamura","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0095","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.acvd.2015.04.002_bib0100","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2013.12.034","volume":"63","author":"O\u2019Malley","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2011.338","article-title":"Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome","volume":"305","author":"Mills","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2015.04.002_bib0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ahj.2014.10.007","article-title":"Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis","volume":"169","author":"Lipinski","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2015.04.002_bib0115","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","article-title":"C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study","volume":"115","author":"Khan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.04.002_bib0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cardfail.2008.07.231","article-title":"C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction","volume":"14","author":"Kelly","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.acvd.2015.04.002_bib0125","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/heartjnl-2013-303975","article-title":"Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction","volume":"99","author":"Reinstadler","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2015.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/eurheartj\/ehp098","article-title":"C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study","volume":"30","author":"Voors","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.04.002_bib0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/hrt.2007.122622","article-title":"Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study","volume":"94","author":"Wu","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2015.04.002_bib0140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrcardio.2012.60","article-title":"Biomarkers in acute heart failure \u2013\u00a0state of the art","volume":"9","author":"Maisel","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"Reichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0150","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.jacc.2010.01.029","article-title":"Copeptin improves early diagnosis of acute myocardial infarction","volume":"55","author":"Keller","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2013.04.011","article-title":"Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction)","volume":"62","author":"Maisel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","article-title":"Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study","volume":"36","author":"Mockel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.04.002_bib0165","first-page":"18","article-title":"Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis","volume":"3","author":"Raskovalova","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.acvd.2015.04.002_bib0170","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2014.01.436","article-title":"A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction","volume":"113","author":"Lipinski","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1515\/cclm-2011-0845","article-title":"Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin","volume":"50","author":"Lippi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.acvd.2015.04.002_bib0180","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.04.002_bib0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.acvd.2015.04.002_bib0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.04.002_bib0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurjhf\/hfr049","article-title":"Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure","volume":"13","author":"Tentzeris","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213615000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213615000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:42:39Z","timestamp":1761745359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213615000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1875213615000893"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2015.04.002","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}